Table 1.
Clinical characteristics of 88 patients | WHO pathological subtypes | P | |||||
---|---|---|---|---|---|---|---|
Type A (n = 9) | Type AB (n = 8) | Type B1 (n = 13) | Type B2 (n = 16) | Type B3 (n = 11) | TC (n = 31) | ||
Sex | 0.042 | ||||||
Male | 3 | 4 | 5 | 5 | 3 | 22 | |
Female | 6 | 4 | 8 | 11 | 8 | 9 | |
Age (mean year) | 54.02 ± 9.93 (range 31–78 years) | ||||||
59.89 ± 12.64 | 57.63 ± 10.56 | 49.23 ± 10.51 | 52.00 ± 7.68 | 47.36 ± 6.53 | 56.81 ± 11.16 | 0.064 | |
Masaoka-Koga stage | <0.001 | ||||||
I | 3 | 2 | 4 | 3 | 0 | 0 | |
II | 5 | 5 | 6 | 5 | 2 | 0 | |
III | 1 | 0 | 3 | 7 | 6 | 6 | |
IV | 0 | 1 | 0 | 1 | 3 | 25 |
TC, thymic carcinoma.